Healthcare Investment in Indonesia: Where Deals Succeed or Stall

Healthcare transactions in Indonesia rarely fail on valuation. They stall on licensing, on facility compliance, and on assumptions about how quickly a provider can expand capacity under current regulation.

Operators, investors, and asset owners benefit from combining sector-specific knowledge with a working understanding of how healthcare regulation is evolving. Diligence should test the licence perimeter of every site, not only the consolidated financials.

Our healthcare advisory work spans transaction support, licensing, and strategic planning, guiding investments through both the commercial decision and the regulatory approval that follows it.